This book focuses on the discovery and validation of biomarkers in pharmacogenomics. It covers techniques for identifying genetic, proteomic, and metabolomic markers that predict drug responses and therapeutic outcomes. The text emphasizes the role of biomarkers in personalized medicine and drug development. Targeted at researchers and clinicians, it provides comprehensive insights into biomarker-driven pharmacogenomic strategies.
Danielle Shaw focuses on discovering biomarkers in pharmacogenomics to predict patient responses to dermatological treatments, enhancing personalized therapy. Her research involves identifying genetic and molecular markers that inform the selection and optimization of skin medications for conditions like psoriasis and eczema. Danielle has authored numerous studies on validating biomarkers that improve treatment precision and outcomes in dermatology. She also offers guidelines for clinicians and researchers to integrate biomarker-based pharmacogenomic strategies into their practice, promoting accurate and personalized dermatological care through informed biomarker utilization.